Organization
Medstar Georgetown University Hospital-Lombardi Comprehensive Cancer Center
2 abstracts
Abstract
RAGE inhibition to decrease cancer therapy related cardiotoxicity in women with early breast cancer (RAGE).Org: Medstar Georgetown University Hospital-Lombardi Comprehensive Cancer Center, Lombardi Cancer Center Georgetown University, Regional Cancer Care Associates, Cantex Pharmaceuticals, Georgetown University Medical Center,
Abstract
A phase I trial of palbociclib (palbo) and bosutinib (bos) with fulvestrant (fulv) in patients (pts) with hormone receptor–positive, HER2-negative (HR+/HER2-) metastatic breast cancer (MBC) refractory to an aromatase inhibitor (AI) and a CDK4/6 inhibitor (CDK4/6i).Org: Medstar Georgetown University Hospital-Lombardi Comprehensive Cancer Center, Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown University, Dana-Farber Cancer Institute, AstraZeneca, Lombardi Comprehensive Cancer Center, Georgetown University,